Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Resignation
Fierce Pharma
George Tidmarsh exits as LinkedIn post sparks lawsuit, probe
A recent LinkedIn post has landed the now-departed CDER chief at the center of an Aurinia lawsuit and an internal probe.
Fraiser Kansteiner
Nov 3, 2025 11:13am
Applied CEO steps down in wake of FDA rejection, warning letter
Dec 20, 2024 12:51pm
vTv CEO resigns four months in and board member takes over
Mar 4, 2022 9:50am
Adagio CEO resigns before COVID-19 antibody makes it to FDA
Feb 22, 2022 11:18am
Athira CEO Kawas out after findings confirm she altered research
Oct 21, 2021 4:29pm
ViaCyte scores $45M for type 1 diabetes drugs in midstage trials
Jun 9, 2021 2:47pm
